Two Lives in One Career

Few careers span such extremes of impact. Fewer still navigate them with equal passion.

Dr. Bednar’s journey, from a small classroom in Hastings, New York, to the frontiers of neurosurgery and pharmaceutical innovation, is not just a story about medicine. It is a story about curiosity, mentorship, reinvention, and the enduring desire to help others.

Medicine was never a late decision or a second act for Dr. Bednar. It was there from the beginning. “It was probably single-digit age,” he recalls. “I thought medicine was what I wanted to go into.”

That clarity carried him from Salesian High School to SUNY Albany and eventually to New York Medical College (NYMC). But it wasn’t just classroom learning that shaped him, it was immersion.

As a college student, Bednar spent summers volunteering at NYMC, and the new Westchester Medical Center, logging extraordinary hours in both the operating room and intensive care unit. It was a time when open-heart surgery was rare, risky, and closely watched. “I’d do eight hours in the operating room and eight hours in the ICU,” he says. “There was this continuity of care… and I just knew, this is what I want to be doing.”

Every career has its turning point. For Dr. Bednar, it came in the form of his NYMC mentor: renowned pharmacologist, the late John C. McGiff, M.D., who was professor and chair of pharmacology at that time. What began as a required assignment, reviewing scientific papers, quickly became something more. He found himself captivated by the emerging field of eicosanoids and arachidonic acid metabolism. Dr. McGiff noticed.

Out of that connection came an unusual opportunity: to help create a new M.D.-Ph.D. pathway at NYMC in partnership with Dr. McGiff. “It had never been done before,” Dr. Bednar says. “So, we had a little latitude on how we were going to organize this.”

The result was seven years of intensive training that blended medicine and research, an experience that would define the rest of his career. “It was a total of seven years, from 1979 to 1986. While I was doing my clerkships, I just finished a few experiments, completed the thesis and some associated publications. It was a very glorious time. If it weren’t for Dr. McGiff,” he reflects, “my career clearly would have taken a very different path.”

Despite his deep engagement in research, Dr. Bednar found himself pulled toward something more immediate: surgery.

Clinical rotations opened his eyes to the precision, complexity, and intensity of neurosurgery. By the time he completed rotations at institutions like Columbia-Presbyterian and NYU, the decision was made. He matched at the University of Vermont, where he would spend six demanding years in neurosurgical residency, often working 100-hour weeks, before joining the faculty. It was a life defined by total immersion. “Your life revolved around what was going on in the hospital,” he says. “But there was incredible camaraderie… you became a real team.”

One moment from that time still stands out: a trauma case in a New York emergency room. “It was completely silent,” he recalls. “People just put out their hands. Instruments went into them. Everyone knew exactly what to do.” For Dr. Bednar, it was a revelation, the power of mastery, coordination, and trust.

Of all his accomplishments, he speaks most passionately about his time as a practicing neurosurgeon. “Every day you get to make a tangible impact on somebody’s life,” he says. “And that impact is deep.”

Unlike many physicians, he structured his rounds to include families, meeting in the evenings so loved ones could be present, ask questions, and better understand frightening diagnoses. “They were scared. They didn’t even know how to pronounce the disease,” he says. “Sitting down with them, that was incredibly meaningful.” It was, in his words, a daily “adrenaline push,” a profound connection between doctor and patient that defined his work.

After years in academia and surgery, Dr. Bednar made a transition that might seem surprising: he entered the pharmaceutical industry. If neurosurgery offered depth, pharma offered scale. “A drug you develop could affect the lives of millions,” he explains. “But you may never meet anybody who takes it.”

One of his most significant contributions came during the development of the antipsychotic drug Geodon. At the time, concerns about cardiac side effects threatened its approval. Though not a cardiologist, Dr. Bednar took on the challenge. Over months of exhaustive research, he analyzed global data on drug-induced cardiac arrhythmias and identified a critical threshold for risk. Armed with this insight, he helped demonstrate the drug’s safety profile to the FDA.

The drug was approved and went on to help countless patients. Years later, he experienced a rare moment of connection when he met someone whose life had been directly improved by the medication. “That was incredibly gratifying,” he says.

After retiring from the pharmaceutical industry in 2025, Dr. Bednar didn’t step away from medicine. Instead, he reimagined his role. He founded Medical Empowerment LLC, a service designed to help patients better understand their conditions, treatment options, and medical language. “I guess you could say I’m a translator,” he says. “People don’t speak medicine.”

Through consultations, he helps patients navigate complex diagnoses, evaluate clinical trials, and prepare for conversations with their doctors. The need is clear: long wait times, overwhelmed physicians, and increasingly complex treatments have left many patients feeling lost. “I want to empower them,” he says, “to feel they have more control over their destiny.”

Throughout his career, Dr. Bednar has gathered insights that extend far beyond the operating room or research lab.

One of the most important: identity should never be confined to a single role. “Being a neurosurgeon wasn’t my identity,” he says. “It was what I was doing at the time.” That perspective was shaped by watching mentors face illness and transition into new roles, continuing to contribute in different ways.

He also emphasizes the importance of mentorship, adaptability, and building strong professional networks, something he wishes he had prioritized earlier.

And then there are the smaller, practical lessons that stay with him: “Always listen to the mother,” he says with a smile, a piece of advice that proved invaluable in pediatric care.

Outside of medicine, Dr. Bednar’s energy shows no signs of slowing down. A lifelong runner, he has logged more than five decades of racing. In recent years, he has taken up competitive short-track speed skating, training and competing alongside athletes decades younger.

He is also an author, having written a trilogy of children’s books inspired by a rescued cat’s recovery from illness, stories of perseverance, empathy, and connection.

Looking back, Dr. Bednar sees his career as a balance between two very different, but equally meaningful forms of impact. One is immediate and personal, the patient in front of you, the family at the bedside. The other is broad and far-reaching, the unseen millions who benefit from a treatment developed years earlier. “It’s hard to say one is better than the other,” he reflects. “I feel blessed to have done both.”

In a world where careers are often defined by specialization, Dr. Bednar’s path stands as a reminder: sometimes the greatest impact comes not from choosing one lane, but from having the courage to travel many.